# The effects of antioxidant supplementation on pain, oxidative stress markers, and clinical pregnancy rate in women with endometriosis: a systematic review and meta-analysis of randomized controlled trials

**Authors:** Yuchan Zhong, Xinyu Qiao, Xin Huang, Yujing Li, Ruiying Wang, Jiagui Liang, Tingting Liu, Wenjie Bo, Huiqiao Lai, Wei Huang

PMC · DOI: 10.3389/fmed.2025.1694281 · Frontiers in Medicine · 2025-10-29

## TL;DR

This study reviews evidence that antioxidant supplements may help reduce pain and oxidative stress in women with endometriosis, but do not improve overall pain or pregnancy rates.

## Contribution

A systematic review and meta-analysis of 21 trials on antioxidant use in endometriosis, revealing specific pain and oxidative stress benefits.

## Key findings

- Antioxidants significantly reduced pelvic pain, dysmenorrhea, and dyspareunia in women with endometriosis.
- Antioxidant supplementation lowered malondialdehyde levels, indicating reduced oxidative stress.
- No significant effects were found on overall pain or clinical pregnancy rates.

## Abstract

Endometriosis is a chronic inflammatory disease characterized by pelvic pain and infertility, with oxidative stress playing a key role in its pathogenesis. Although antioxidant supplementation has been proposed as a potential adjunctive therapy in endometriosis, current evidence regarding its efficacy in symptom relief and fertility improvement remains inconclusive. This systematic review and meta-analysis included 21 randomized controlled trials involving 1,626 participants and evaluated more than 10 types of antioxidant supplementation, including vitamins, pentoxifylline, melatonin, astaxanthin, fish oil, and silymarin. The results showed that antioxidant supplementation significantly alleviated pelvic pain (continuous outcomes: SMD = −2.68; p < 0.00001; binary outcomes: RR = 9.31; p < 0.0001), dysmenorrhea (SMD = −1.77; p = 0.01; RR = 2.39; p = 0.03), and dyspareunia (SMD = −2.33; p = 0.01; RR = 5.40; p = 0.003), and significantly decreased peripheral blood malondialdehyde (MDA) levels (SMD = −7.58; p = 0.001). However, no significant effects were observed on overall pain (SMD = −1.14; p = 0.51) or clinical pregnancy rate (RR = 1.12; p = 0.52). Subgroup analyses further indicated that treatment efficacy varied by antioxidant type, disease stage, and duration of intervention. These findings suggest that antioxidant supplementation may offer therapeutic benefits in alleviating specific pain symptoms and reducing oxidative stress in women with endometriosis. Further large-scale and high-quality randomized controlled trials are needed to validate these results and establish optimal antioxidant strategies for long-term management of endometriosis.

PROSPERO CRD420251071723, https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420251071723.

## Linked entities

- **Chemicals:** pentoxifylline (PubChem CID 4740), melatonin (PubChem CID 896), astaxanthin (PubChem CID 5281224), silymarin (PubChem CID 5213), malondialdehyde (PubChem CID 10964)
- **Diseases:** endometriosis (MONDO:0005133)

## Full-text entities

- **Diseases:** infertility (MESH:D007246), Endometriosis (MESH:D004715), pain (MESH:D010146), inflammatory disease (MESH:D007249), dyspareunia (MESH:D004414), dysmenorrhea (MESH:D004412), pelvic pain (MESH:D017699)
- **Chemicals:** astaxanthin (MESH:C005948), silymarin (MESH:D012838), pentoxifylline (MESH:D010431), fish oil (MESH:D005395), MDA (MESH:D008315), melatonin (MESH:D008550)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12605171/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12605171/full.md

## References

70 references — full list in the complete paper: https://tomesphere.com/paper/PMC12605171/full.md

---
Source: https://tomesphere.com/paper/PMC12605171